H

Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627

Watchlist Manager
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Watchlist
Price: 4.01 CNY -4.3% Market Closed
Market Cap: 19.8B CNY
Have any thoughts about
Hubei Biocause Pharmaceutical Co Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one Hubei Biocause Pharmaceutical Co Ltd stock under the Base Case scenario is 4.32 CNY. Compared to the current market price of 4.01 CNY, Hubei Biocause Pharmaceutical Co Ltd is Undervalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
4.32 CNY
Undervaluation 7%
Relative Value
Price
H
Worst Case
Base Case
Best Case

Valuation Multiples

0.4
P/S
P/S
Price to Sales
0.4
vs History
38
vs Industry
92
Median 3Y
0.3
Median 5Y
0.3
Industry
1.1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
8
Median 3Y
34.2
Median 5Y
25
Industry
12.7
More Details
1
P/B
P/B
Price to Book Value
1
vs History
26
vs Industry
87
Median 3Y
0.7
Median 5Y
0.8
Industry
1.5
More Details
0.5
Price/Premiums
Price/Premiums
Price to Premiums
0.5
vs History
39
vs Industry
92
Median 3Y
0.4
Median 5Y
0.4
Industry
1.2
More Details

Multiples Across Competitors

Competitors Multiples
Hubei Biocause Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
P/B
All Countries
All Countries
Close
Market Cap P/S P/E P/B
CN
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
19.8B CNY 0.4 -23.9 1
ZA
Sanlam Ltd
JSE:SLM
184.9B Zac 0 0 0
CN
Ping An Insurance Group Co of China Ltd
SSE:601318
960.2B CNY 1.2 8.2 1
ZA
Discovery Ltd
JSE:DSY
131.8B Zac 0 0 0
CN
China Life Insurance Co Ltd
SSE:601628
869.8B CNY 2.2 7.9 1.8
ZA
OUTsurance Group Ltd
JSE:OUT
100.9B Zac 0 0 0
HK
AIA Group Ltd
HKEX:1299
629B HKD 3.8 16.7 2.1
IN
Life Insurance Corporation Of India
NSE:LICI
5.6T INR 0.6 13.5 6.8
ZA
Old Mutual Ltd
JSE:OMU
63.2B Zac 0 0 0
US
Aflac Inc
NYSE:AFL
62.6B USD 3.6 16.4 2.5
US
MetLife Inc
NYSE:MET
60.1B USD 0.8 16.9 1.9

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 201,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.